MedPath
HSA Approval

CLARITYNE SYRUP 5 MG/5 ML (GRAPE FLAVOR)

SIN16091P

CLARITYNE SYRUP 5 MG/5 ML (GRAPE FLAVOR)

CLARITYNE SYRUP 5 MG/5 ML (GRAPE FLAVOR)

January 29, 2021

BAYER (SOUTH EAST ASIA) PTE LTD

BAYER (SOUTH EAST ASIA) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantBAYER (SOUTH EAST ASIA) PTE LTD
Licence HolderBAYER (SOUTH EAST ASIA) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

SYRUP

ORAL

Medical Information

R06AX13

loratadine

Manufacturer Information

BAYER (SOUTH EAST ASIA) PTE LTD

Delpharm Montréal Inc.

Active Ingredients

Loratadine

5 mg/ 5mL

Loratadine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.